<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="openVirus\examples\priya950\4-part\PMC7173960\results\search\disease\results.xml">
  <result pre="development of bunyavirus antiviral therapies. bunyavirus therapy single-domain antibody vhh" exact="rift valley fever" post="virus schmallenberg virus Research organism Virus Funding http://dx.doi.org/10.13039/501100010767Innovative Medicines"/>
  <result pre="severe flu-like symptoms, however a minority of patients may develop" exact="encephalitis" post="or hemorrhagic fever. In addition to members of the"/>
  <result pre="RVFV, Crimean-Congo hemorrhagic fever virus (CCHFV) and severe fever with" exact="thrombocytopenia" post="syndrome virus (SFTSV), on the Blueprint list of viruses"/>
  <result pre="assembly strategy may also facilitate the development of biotherapeutics targeting" exact="cancer" post="and toxins. Interestingly, a related approach primarily based on"/>
  <result pre="is expected to provide novel opportunities for the development of" exact="cancer" post="and toxin biotherapeutics. Materials and methods Key resources table"/>
  <result pre="the RVFV VLP antigen, this llama was also immunized with" exact="influenza" post="antigens for a different study (Harmsen et al., 2013)."/>
  <result pre="llama Single-Domain antibody fragments binding all nine neuraminidase subtypes of" exact="influenza" post="A virusAntibodies216819210.3390/antib2020168 HarmsenMMDe HaardHJ2007aProperties, production, and applications of camelid"/>
 </snippets>
</snippetsTree>
